Skip to contentA
Adicet Bio, Inc.
A
ACETAdicet Bio, Inc. Released Aug 14, 2019, before the open
10-Q filed Aug 14, 2019, 45 days after period end · 0001564590-19-032151
Q2 2019 · 10-Q
Revenue—
Net Income-$2.65M-$2.65MN/M vs Q2 2018N/M vs Q1 2019 EPS Diluted
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Adicet Bio, Inc. · CIK 1720580 · Engraved from SEC EDGAR
-$0.51-$0.51N/M vs Q2 2018N/M vs Q1 2019 Operating Income-$19,169,000N/M Operating Cash Flowderived-$14,175,000N/M Free Cash Flowderived-$14,199,000N/M ended Jun 30, 2019 · filed Aug 14, 2019 · 45 d after period end